The shares of this small-cap stock, engaged in the business of manufacturing specialty chemicals gained attention in Tuesday’s trading session after signing a Rs. 922 crore Letter of Intent with a leading Korean multinational for the supply of a high-performance specialty chemical from FY26.
Stock Performance
With a market capitalization of Rs. 8,730.20 crore, Anupam Rasayan India Ltd jumped 3 percent Tuesday’s trading session to an intraday high of Rs. 810.55 per share compared to its previous closing price of Rs. 787.70 per share. The stock retraced from its day’s high and was trading at Rs. 794 which is 1 percent higher compared to the previous closing price.
What Happened
Anupam Rasayan India Ltd. has secured a 10-year letter of intent worth USD 106 million (Rs. 922 crores) with a leading Korean multinational in specialty chemicals. The agreement involves supplying a high-performance niche chemical starting from FY26. This partnership enhances Anupam’s global footprint and underscores its expertise in advanced chemical solutions.
Management Commentary
Gopal Agrawal, CEO of Anupam Rasayan, said, “…The specialty chemical covered under this agreement has niche applications in the aviation and electronics sectors. With our robust backward integration capabilities, we ensure a stable and efficient supply chain, offering reliability and consistency to our global customers. Expanding into South Korea adds another significant geography to Anupam Rasayan’s global presence, positioning the company for long-term growth in one of the world’s most advanced manufacturing hubs.”
Company Overview
Anupam Rasayan India Ltd specializes in custom synthesis and manufacturing of specialty chemicals across agrochemicals, pharmaceuticals, and personal care. It produces agro intermediates for insecticides, fungicides, and herbicides, along with anti-bacterial and UV protection ingredients for personal care. In pharmaceuticals, it develops intermediates for active ingredients.
Financial Performance
In the latest quarter, Anupam Rasayan reported a 32 percent YoY increase in its revenue from Rs. 296 crore to Rs. 390 crore. On a quarterly basis however, there was a 33 percent increase from Rs. 294 crore in Q2 FY25.
The net profits witnessed a significant 108 percent growth from Rs. 26 crore to Rs. 54 crore. This was accompanied by a 74 percent QoQ increase in net profits from Rs. 31 crore in Q2 FY25.
Written by Shwetha Sairam
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
